1. Autotransplants for Lymphoid Neoplasms Increase the Risks of MDS More Than AML. (April 2017) Authors: Radivoyevitch, T.; Millard, H.; Shaw, B.; Brazauskas, R.; Savani, B.; Flowers, M.E.; Battiwalla, M.; Hamilton, B.K.; Sekeres, M.; Maciejewski, J.; Litzow, M.; Gale, R.P.; Dean, R.M.; Hashmi, S. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients. Issue 2 (1st April 2016) Authors: Damlaj, M.; Bartoo, G.; Cartin‐Ceba, R.; Gijima, D.; Alkhateeb, H.B.; Merten, J.; Hashmi, S.; Litzow, M.; Gastineau, D.; Hogan, W.; Patnaik, M.M. Journal: Transplant infectious disease Issue: Volume 18:Issue 2(2016) Page Start: 216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1323: PREDICTION OF NON-RELAPSE MORTALITY BY EASIX AND HCT-CI SCORES IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT. (23rd June 2022) Authors: Baranwal, A.; Mangaonkar, A.; Shah, M.; Litzow, M.; Hogan, W.; Patnaik, M.; Alkhateeb, H. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P540: PEVONEDISTAT, AZACITIDINE AND VENETOCLAX FOR PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA– A PHASE I STUDY. (23rd June 2022) Authors: Guru Murthy, G. S.; Kaufmann, S.; Saliba, A.; Szabo, A.; Michaelis, L.; Abedin, S.; Runaas, L.; Carlson, K.; Maldonado-Schmidt, S.; Hinman, A.; Thomas, A.; Baim, A.; Litzow, M.; Atallah, E. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P544: MOLECULAR PREDICTORS OF RESPONSE AND SURVIVAL IN TREATMENT-NAÏVE PATIENTS WITH ACUTE MYELOID LEUKEMIA FOLLOWING VENETOCLAX AND HYPOMETHYLATING AGENTS. (23rd June 2022) Authors: Johnson, I.; McCullough, K.; Farrukh, F.; Al-Kali, A.; Alkhateeb, H.; Begna, K.; Mangaonkar, A.; Litzow, M.; Hogan, W.; Shah, M.; Patnaik, M.; Pardanani, A.; Tefferi, A.; Gangat, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗